Eli Lilly's Zepbound in shortage months after approval [Yahoo! Finance]
Comcast Corporation - Class A (CMCSA)
Last comcast corporation - class a earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
cmcsa.com/investors
Company Research
Source: Yahoo! Finance
As of this week, most tirzepatide injections (sold commercially as Mounjaro and Zepbound) have limited availability, according to the FDA's shortage database. The cited reason for all the shortages of tirzepatide is “demand increase for the drug.” The FDA approved Zepbound for weight loss in November. Tirzepatide was already being sold on the market as the diabetes treatment Mounjaro, though off-label use for weight loss did occur prior to Zepbound's approval. “We have experienced an unparalleled surge in demand for our type 2 diabetes and obesity medicines. As a result, there is limited availability of several doses of Mounjaro® (tirzepatide), Zepbound® (tirzepatide) and Trulicity® (dulaglutide) in the U.S,” a spokesperson for Eli Lilly told The Hill in a statement. “We recognize this situation may cause a disruption in peoples' treatment regimens and are working with purpose and urgency to help meet the surge in demand,” the spokesperson added. “As a medicine company, we know
Show less
Read more
Impact Snapshot
Event Time:
CMCSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMCSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMCSA alerts
High impacting Comcast Corporation - Class A news events
Weekly update
A roundup of the hottest topics
CMCSA
News
- The 2024 Avian Flu: Origins, Impact, And The Global Response [Forbes]Forbes
- Drake And Kendrick Lamar Feud Timeline: Drake Seemingly Responds To ‘Euphoria' Diss Track On Instagram [Forbes]Forbes
- ‘Dune': The Battle For Arrakis Looms Large In Spice-Filled Sneak Peek At Abrams' Graphic Novel Conclusion [Forbes]Forbes
- THEN AND NOW: The cast of 'Seinfeld' 35 years later [Business Insider]Business Insider
- How an early Kanye West scandal showed Adidas' massive DEI shortcomings [Fortune]Fortune
CMCSA
Earnings
- 4/25/24 - Beat
CMCSA
Sec Filings
- 4/26/24 - Form DEF
- 4/26/24 - Form DEFA14A
- 4/25/24 - Form 10-Q
- CMCSA's page on the SEC website